Youtube
DRREDDY

Dr Reddy's Laboratories Ltd Share Price

₹4309.65

Score

43

Technically Neutral

Advice

Dr. Reddy's Laboratories Share Price - 1 Year Trend

Dr. Reddy's Laboratories Price Change Analysis

Dr. Reddy's Laboratories Key Statistics
  • P/E Ratio

    44.2

  • PEG Ratio

    2.8

  • Market Cap Cr

    71730.2

  • Price to Book Ratio

    1101.7

  • EPS

    97.5

  • Dividend

    600 ()

  • Relative Strength Index

    54.91

  • Money Flow Index

    52.68

  • MACD Signal

    27.32

  • Average True Range

    109.27

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Dr. Reddy's Laboratories Synopsis

NSE-Medical-Diversified

Dr. Reddy's Labs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 13349.10 Cr. and Equity Capital is Rs. 83.20 Cr. for the Year ended 31/03/2021. Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507.
  • Market Cap

    71,730.24

  • Sales

    14,405.20

  • Shares in Float

    12.15

  • No of Funds

    696

  • Yield

    0.7

  • Book Value

    3.91

  • U/D Vol Ratio

    1.5

  • LTDebt/Equity

    0

  • Alpha

    -0.07

  • Beta

    0.65

Dr. Reddy's Laboratories Ownership
Dr. Reddy's Laboratories Management

Dr. Reddy's Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Dr. Reddy's Laboratories Financials

Dr. Reddy's Laboratories Technicals

EMA & SMA

CURRENT PRICE

EMA

Dr. Reddy's Laboratories Resistance and Support

Dr. Reddy's Laboratories Delivery and Volume

Dr. Reddy's Laboratories Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Dr Reddys Laboratories stock price CAGR for 10 Years stands at 12%, 5 Years at 8%, 3 Years at 20%, and 1 Year at -2%.

The ROE of Dr Reddys Laboratories is 11%.

Dr Reddy's Laboratories has an operating revenue of Rs. 20,442.10 Cr. on a trailing 12-month basis. Annual revenue growth of 7% is good, Pre-tax margin of 15% is great. As per analysts rating in the last 6 months, the recommendation is to HOLD Dr Reddys Laboratories.

Erez Israeli is the Chief Executive Officer (CEO) at Dr Reddy's Laboratories since 1 Aug 2019.

Dr. Reddy's Laboratories share price is ₹4309 As on 26 June, 2022 | 17:34
The Market Cap of Dr. Reddy's Laboratories is ₹71730.2 As on 26 June, 2022 | 17:34
The P/E ratio of Dr. Reddy's Laboratories is 32.9 As on 26 June, 2022 | 17:34
The PB ratio of Dr. Reddy's Laboratories is 3.7 As on 26 June, 2022 | 17:34
The 52 week High & Low of Dr. Reddy's Laboratories is ₹5614.6/₹3654 respectively As on 26 June, 2022 | 17:34
Open Demat Account